Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial
Published Online: 2016-11-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Alex Azrilevich•Chen-Sheng Lin•Chris Harbison•Dirk Jaeger•Dung T Le•Emiliano Calvo•Emily Chan•Filippo de Braud•Jonathan E Rosenberg•Joseph Kim•Margaret K Callahan•Marina Tschaika•Michael Morse•Padmanee Sharma•Patrick A Ott•Pavlina Spiliopoulou•Petri Bono•Rathi N Pillai
